Nigella sativa for the treatment of COVID-19: An open-label randomized controlled clinical trial.
Koshak AE, Koshak EA, Mobeireek AF, Badawi MA, Wali SO, Malibary HM, Atwah AF, Alhamdan MM, Almalki RA, Madani TA.
Koshak AE, et al. Among authors: koshak ea.
Complement Ther Med. 2021 Sep;61:102769. doi: 10.1016/j.ctim.2021.102769. Epub 2021 Aug 15.
Complement Ther Med. 2021.
PMID: 34407441
Free PMC article.
Clinical Trial.